United States resistance surveillance results for linezolid (LEADER Program for 2007).
about
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy.Emergence of linezolid resistance in a clinical Staphylococcus capitis isolate from Jiangsu Province of China in 2012.Polyphyletic emergence of linezolid-resistant staphylococci in the United StatesMechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, OhioLEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States.Antimicrobial resistance surveillance systems: Are potential biases taken into account?Linezolid surveillance results for the United States: LEADER surveillance program 2011.Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).EsxA might as a virulence factor induce antibodies in patients with Staphylococcus aureus infection.Antimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran.In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United StatesEmerging drugs for complicated skin and skin-structure infections.Novel heterodimer antibiotics: a review of recent patent literature.Linezolid, the first oxazolidinone antibacterial agent.Antibiotic resistance in Enterococcus faecium clinical isolates.Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United StatesNovel antibiotics for the treatment of Staphylococcus aureus.Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries.Genetic environment and stability of cfr in methicillin-resistant Staphylococcus aureus CM05.Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals.Pediatric antimicrobial susceptibility trends across the United States.
P2860
Q26745991-130AAB38-AB73-4EEA-8A17-65F0510DD56CQ31114532-50F1942C-34F0-4C2F-99BF-DE6C56F912A9Q33586058-DD632071-720F-43AB-9BBC-7FDD5EE7AB26Q33613747-4A3EDCDC-89D1-462C-A4B6-5B3C38339564Q33648052-10162BE0-7699-4F24-8398-B1F1E76ECC8BQ34737606-38291B23-6A90-4279-8364-A4DEBB9C1DCDQ35139437-6E4B13D3-3F6C-4339-B801-9000608876DBQ35569208-81635B4C-DA9A-4316-820C-85F363FD472CQ36558466-3FF37C35-D349-4E05-B8D5-6E8B1D19DCCBQ36730155-012321C5-B220-4B81-A363-87201D6C7353Q37244565-F2271AA3-7834-4926-A900-F1EFAD187577Q37374748-4163BC50-48CE-4E8A-AF45-C1B5CC4BF50AQ37428616-D38B9588-4BA3-49D5-BEC9-B243830A6CCFQ37544790-02E5BA53-9A67-4B94-A22E-5288A0A62FE2Q37765900-EDF93548-20C5-4685-90BC-26FE692C87FDQ37855823-259E40D2-34AC-4F48-87D7-CF6D41EF7AD4Q37857331-AE7FCCFF-6407-4612-A968-D41151CC608BQ38176042-C6DD22A1-1543-4610-B98F-C12A24F3EF48Q39682411-776D599E-EA12-4C07-AC70-3DB54EB874EEQ39933945-ABE373FB-D5A3-4DDB-8012-1FB6BEADC997Q42037140-44DF7144-922A-4AB1-8285-8811CF06F39AQ42285540-6CDC31B6-E96D-44FD-A562-AA205230F5D5Q43053544-EA4541EE-8EAF-4D2C-8FBF-44CC1AB78620Q43195362-5B8687D6-E792-4E87-AC4C-D9886427ACC3Q44387036-098E7C8B-96BC-41A5-8751-DF013BBB3CB5
P2860
United States resistance surveillance results for linezolid (LEADER Program for 2007).
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@ast
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@en
United States resistance surveillance results for linezolid
@nl
type
label
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@ast
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@en
United States resistance surveillance results for linezolid
@nl
prefLabel
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@ast
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@en
United States resistance surveillance results for linezolid
@nl
P2093
P1476
United States resistance surveillance results for linezolid (LEADER Program for 2007).
@en
P2093
James E Ross
Rodrigo E Mendes
Ronald N Jones
P304
P356
10.1016/J.DIAGMICROBIO.2008.10.010
P577
2008-12-01T00:00:00Z